Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 3,837 TARS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 3,837 | n/a |
| Jun 22, 2026 | Zai Lab Ltd (ZLAB) | Grant/Award | 22,371 | n/a |
| Jun 18, 2026 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 20,000 | n/a |
| Jun 16, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,954 | n/a |
| May 26, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 17,084 | n/a |
| Sep 16, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 1,334 | n/a |
| Jun 26, 2025 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 20,000 | n/a |
| Jun 23, 2025 | Zai Lab Ltd (ZLAB) | Grant/Award | 10,831 | n/a |
| Jun 16, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| Jun 16, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 3,350 | n/a |